Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

M is for MAVIRET

News, A to Z Feature 28/02/2025

A to Z: Drugs in Highlight: M is for MAVIRET®

Secerna Interior Shots September 2024 022 (1)

News, Careers 25/02/2025

Explore a Career in IP: Secerna Taster Day

LEQEMBI

News, A to Z Feature 19/02/2025

A to Z: Drugs in Highlight: L is for LEQEMBI®

Secerna Website Images 2025 (5)

Events, News 17/02/2025

Secerna LLP are presenting at NEPIC Pharma Connect 2025

Secerna Website Images 2025 (6)

Events, News 14/02/2025

Secerna attending Agri-Tech Expo North

KALYDECO

News, A to Z Feature 13/02/2025

A to Z: Drugs in Highlight: K is for KALYDECO®

News 11/02/2025

Protect Your Global Brand: Essential Trade Mark Services

J Is For JANUVIA® (1)

News, A to Z Feature 06/02/2025

A to Z: Drugs in Highlight: J is for JANUVIA®

EU FLAG Canva

Industry news, News 03/02/2025

UPC finds infringement by way of equivalence for the first time

1 2 3 4 5 6 7 8 9